Pricing
Login
Home
Charts
Search
Watchlist
Products

ERIS Lifesciences Ltd

ERIS
₹1,317.20-0.89%20 Nov 2026
Reports
Pharma Formulations

ERIS Lifesciences Ltd

ERIS
₹1,317.20
-0.89%
20 Nov 2026
Ask AI
6M
Price
Charts
Documents

Quick Ratios

Edit Ratios
Mkt Cap
Market Capitalization
₹18,275Cr
Close
Close Price
₹1,317.20
Industry
Industry
Pharma Formulations
PE
Price To Earnings
25.60
PS
Price To Sales
5.49
Revenue
Revenue
₹3,330Cr
Rev Gr TTM
Revenue Growth TTM
11.06%
PAT Gr TTM
PAT Growth TTM
60.00%

Quarterly Results

Consolidated
Standalone
Numbers
Percentage
QuarterDec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026Sep 2026
Revenue
RevenueCr
486551720741727705773792807757873892
Growth YoY
Revenue Growth YoY%
14.936.854.246.749.628.07.46.911.07.313.012.6
Expenses
ExpensesCr
311403470477477453496504526483577583
Operating Profit
Operating ProfitCr
176148250265250252277288282274296309
OPM
OPM%
36.126.934.735.734.435.835.836.434.936.233.934.7
Other Income
Other IncomeCr
415254843-1712-34
Interest Expense
Interest ExpenseCr
183360595754495049464746
Depreciation
DepreciationCr
465476808177716970707273
PBT
PBTCr
11677116129116129161173145159179156
Tax
TaxCr
14-326332927363837-12036-31
PAT
PATCr
10180909687102125134109279143187
Growth YoY
PAT Growth YoY%
1.229.6-4.4-21.2-14.228.439.739.625.0172.714.639.2
NPM
NPM%
20.914.512.413.012.014.516.217.013.536.916.421.0
EPS
EPS₹
7.55.26.16.76.26.98.78.87.320.610.313.3
QuarterDec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026Sep 2026
Revenue
RevenueCr
486551720741727705773792807757873892
Growth YoY
Revenue Growth YoY%
14.936.854.246.749.628.07.46.911.07.313.012.6
Expenses
ExpensesCr
311403470477477453496504526483577583
Operating Profit
Operating ProfitCr
176148250265250252277288282274296309
OPM
OPM%
36.126.934.735.734.435.835.836.434.936.233.934.7
Other Income
Other IncomeCr
415254843-1712-34
Interest Expense
Interest ExpenseCr
183360595754495049464746
Depreciation
DepreciationCr
465476808177716970707273
PBT
PBTCr
11677116129116129161173145159179156
Tax
TaxCr
14-326332927363837-12036-31
PAT
PATCr
10180909687102125134109279143187
Growth YoY
PAT Growth YoY%
1.229.6-4.4-21.2-14.228.439.739.625.0172.714.639.2
NPM
NPM%
20.914.512.413.012.014.516.217.013.536.916.421.0
EPS
EPS₹
7.55.26.16.76.26.98.78.87.320.610.313.3

Profit & Loss

Consolidated
Standalone
Numbers
Percentage
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Revenue
RevenueCr
6057508569821,0741,2121,3471,6852,0092,8943,1293,330
Growth
Revenue Growth%
10.923.914.214.89.412.811.225.119.244.08.211.1
Expenses
ExpensesCr
4354805346377067818621,1481,3341,8762,0092,169
Operating Profit
Operating ProfitCr
1702693223453684314855376751,0171,1201,161
OPM
OPM%
28.135.937.635.134.335.536.031.933.635.135.834.9
Other Income
Other IncomeCr
-3025263215926112418-9-48
Interest Expense
Interest ExpenseCr
0111232242685231193188
Depreciation
DepreciationCr
20232636504365117183315280285
PBT
PBTCr
121270312317331395442405431489639640
Tax
TaxCr
52417263539363034114-9-78
PAT
PATCr
116247295291297355406374397375648718
Growth
PAT Growth%
29.6113.219.6-1.31.819.814.3-7.86.1-5.772.860.0
NPM
NPM%
19.132.934.529.627.629.330.122.219.812.920.721.6
EPS
EPS₹
8.417.921.421.121.626.229.928.128.825.945.351.5
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Revenue
RevenueCr
6057508569821,0741,2121,3471,6852,0092,8943,1293,330
Growth
Revenue Growth%
10.923.914.214.89.412.811.225.119.244.08.211.1
Expenses
ExpensesCr
4354805346377067818621,1481,3341,8762,0092,169
Operating Profit
Operating ProfitCr
1702693223453684314855376751,0171,1201,161
OPM
OPM%
28.135.937.635.134.335.536.031.933.635.135.834.9
Other Income
Other IncomeCr
-3025263215926112418-9-48
Interest Expense
Interest ExpenseCr
0111232242685231193188
Depreciation
DepreciationCr
20232636504365117183315280285
PBT
PBTCr
121270312317331395442405431489639640
Tax
TaxCr
52417263539363034114-9-78
PAT
PATCr
116247295291297355406374397375648718
Growth
PAT Growth%
29.6113.219.6-1.31.819.814.3-7.86.1-5.772.860.0
NPM
NPM%
19.132.934.529.627.629.330.122.219.812.920.721.6
EPS
EPS₹
8.417.921.421.121.626.229.928.128.825.945.351.5
Sales CAGR
1 Year8%
3 Years23%
5 Years21%
TTM11%
EBITDA CAGR
1 Year10%
3 Years28%
5 Years21%
TTM9%
PAT CAGR
1 Year73%
3 Years20%
5 Years13%
TTM60%
Avg. ROCE
1 Year13%
3 Years12%
5 Years15%
TTM13%
CFO / EBITDA
1 Year48%
3 Years74%
5 Years72%
TTM-

Balance Sheet

Consolidated
Standalone
Numbers
Percentage
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026Sep 2026
Equity Capital
Equity CapitalCr
01414141414141414141414
Reserves
ReservesCr
3025538481,1371,2831,5631,8942,1822,5732,8413,8894,130
Current Liabilities
Current LiabilitiesCr
71762253061651672004432,5321,3852,0772,681
Non Current Liabilities
Non Current LiabilitiesCr
25603497991911641,0031,2862,3801,393758
Total Liabilities
Total LiabilitiesCr
3987271,4601,5541,5521,8352,2723,6677,0407,0367,3667,581
Current Assets
Current AssetsCr
2372162995824804676277652,3021,2261,5401,801
Non Current Assets
Non Current AssetsCr
1615111,1619721,0731,3681,6452,9034,7385,8105,8265,780
Total Assets
Total AssetsCr
3987271,4601,5541,5521,8352,2723,6677,0407,0367,3667,581
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026Sep 2026
Equity Capital
Equity CapitalCr
01414141414141414141414
Reserves
ReservesCr
3025538481,1371,2831,5631,8942,1822,5732,8413,8894,130
Current Liabilities
Current LiabilitiesCr
71762253061651672004432,5321,3852,0772,681
Non Current Liabilities
Non Current LiabilitiesCr
25603497991911641,0031,2862,3801,393758
Total Liabilities
Total LiabilitiesCr
3987271,4601,5541,5521,8352,2723,6677,0407,0367,3667,581
Current Assets
Current AssetsCr
2372162995824804676277652,3021,2261,5401,801
Non Current Assets
Non Current AssetsCr
1615111,1619721,0731,3681,6452,9034,7385,8105,8265,780
Total Assets
Total AssetsCr
3987271,4601,5541,5521,8352,2723,6677,0407,0367,3667,581

Cash Flow

Consolidated
Standalone
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating Cash Flow
Operating Cash FlowCr
1332002352232713753782924861,065538
Investing Cash Flow
Investing Cash FlowCr
-45-184-590-5123-323-320-982-1,855-80-369
Financing Cash Flow
Financing Cash FlowCr
-84-24363-221-335-82-456881,380-881-314
Net Cash Flow
Net Cash FlowCr
4-88-360-3014-211104-145
Free Cash Flow
Free Cash FlowCr
109151210186125350258-550357910241
CFO To PAT
CFO To PAT%
114.781.279.576.691.5105.793.278.0122.4284.383.1
CFO To EBITDA
CFO To EBITDA%
78.074.472.964.773.687.278.054.472.0104.748.0
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating Cash Flow
Operating Cash FlowCr
1332002352232713753782924861,065538
Investing Cash Flow
Investing Cash FlowCr
-45-184-590-5123-323-320-982-1,855-80-369
Financing Cash Flow
Financing Cash FlowCr
-84-24363-221-335-82-456881,380-881-314
Net Cash Flow
Net Cash FlowCr
4-88-360-3014-211104-145
Free Cash Flow
Free Cash FlowCr
109151210186125350258-550357910241
CFO To PAT
CFO To PAT%
114.781.279.576.691.5105.793.278.0122.4284.383.1
CFO To EBITDA
CFO To EBITDA%
78.074.472.964.773.687.278.054.472.0104.748.0

Ratios

Consolidated
Standalone
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026Current
Valuation Ratios
Valuation Ratios
Market Cap
Market CapitalizationCr
10,9278,8575,0048,2079,3677,77911,44319,28717,98618,275
Price To Earnings
Price To Earnings
37.130.416.923.123.120.429.254.829.025.6
Price To Sales
Price To Sales
12.89.04.76.87.04.55.66.75.85.5
Price To Book
Price To Book
12.77.73.95.24.93.54.46.84.64.4
EV To EBITDA
EV To EBITDA
34.825.713.419.019.416.019.021.218.117.6
Profitability Ratios
Profitability Ratios
GPM
GPM%
79.780.982.583.582.679.479.977.979.372.771.771.7
OPM
OPM%
28.135.937.635.134.335.536.031.933.635.135.834.9
NPM
NPM%
19.132.934.529.627.629.330.122.219.812.920.721.6
ROCE
ROCE%
40.047.828.429.625.725.022.414.09.613.513.312.7
ROE
ROE%
38.343.534.325.322.922.521.317.015.413.116.617.3
ROA
ROA%
29.133.920.218.719.119.417.910.25.65.38.89.5
Operational Ratios
Operational Ratios
Solvency Ratios
Solvency Ratios
Liquidity Ratios
Liquidity Ratios
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026Current
Valuation Ratios
Valuation Ratios
Market Cap
Market CapitalizationCr
10,9278,8575,0048,2079,3677,77911,44319,28717,98618,275
Price To Earnings
Price To Earnings
37.130.416.923.123.120.429.254.829.025.6
Price To Sales
Price To Sales
12.89.04.76.87.04.55.66.75.85.5
Price To Book
Price To Book
12.77.73.95.24.93.54.46.84.64.4
EV To EBITDA
EV To EBITDA
34.825.713.419.019.416.019.021.218.117.6
Profitability Ratios
Profitability Ratios
GPM
GPM%
79.780.982.583.582.679.479.977.979.372.771.771.7
OPM
OPM%
28.135.937.635.134.335.536.031.933.635.135.834.9
NPM
NPM%
19.132.934.529.627.629.330.122.219.812.920.721.6
ROCE
ROCE%
40.047.828.429.625.725.022.414.09.613.513.312.7
ROE
ROE%
38.343.534.325.322.922.521.317.015.413.116.617.3
ROA
ROA%
29.133.920.218.719.119.417.910.25.65.38.89.5
Operational Ratios
Operational Ratios
Solvency Ratios
Solvency Ratios
Liquidity Ratios
Liquidity Ratios
Market CapitalizationMkt CapCr28,45122,44020,46118,27515,97415,42414,894
Close PriceClose₹1,718.70822.651,040.951,317.20814.302,029.10935.05
IndustryIndustryPharma FormulationsPharma FormulationsPharma FormulationsPharma FormulationsPharma FormulationsPharma FormulationsPharma Formulations
Price To EarningsPE87.0728.4724.2525.6017.7422.3856.29
Price To SalesPS13.553.812.415.495.176.471.65
RevenueRevenueCr2,1005,8958,4773,3303,0892,3839,012
Revenue Growth TTMRev Gr TTM%46.3%21.8%19.7%11.1%-29.6%16.8%18.3%
PAT Growth TTMPAT Gr TTM%89.4%39.1%32.9%60.0%-56.4%17.4%-44.7%
Market CapitalizationMkt CapCr28,45122,44020,46118,27515,97415,42414,894
Close PriceClose₹1,718.70822.651,040.951,317.20814.302,029.10935.05
IndustryIndustryPharma FormulationsPharma FormulationsPharma FormulationsPharma FormulationsPharma FormulationsPharma FormulationsPharma Formulations
Price To EarningsPE87.0728.4724.2525.6017.7422.3856.29
Price To SalesPS13.553.812.415.495.176.471.65
RevenueRevenueCr2,1005,8958,4773,3303,0892,3839,012
Revenue Growth TTMRev Gr TTM%46.3%21.8%19.7%11.1%-29.6%16.8%18.3%
PAT Growth TTMPAT Gr TTM%89.4%39.1%32.9%60.0%-56.4%17.4%-44.7%
Annual Reports
FY2026
FY2025
FY2024
FY2023
FY2022
FY2021
FY2020
Quarterly Reports
FY2026
Mar 26
ResultPPT
Transcript
Summary
Dec 25
ResultPPT
Transcript
Summary
Sep 25
ResultPPT
Transcript
Summary
Jun 25
ResultPPT
Transcript
Summary
Mar 25
ResultPPT
Transcript
Summary
Dec 24
ResultPPT
Transcript
Summary
Sep 24
ResultPPT
Transcript
Summary
Jun 24
ResultPPT
Transcript
Summary
Dec 23
ResultPPT
Transcript
Summary
Sep 23
ResultPPT
Transcript
Summary
Jun 23
ResultPPT
Transcript
Summary
Mar 23
ResultPPT
Transcript
Summary
Sep 22
ResultPPT
Transcript
Summary
Jun 22
ResultPPT
Transcript
Summary
Mar 22
ResultPPT
Transcript
Summary
Dec 21
ResultPPT
Transcript
Summary
Sep 21
ResultPPT
Transcript
Summary
Jun 21
Result
PPT
Transcript
Summary
Mar 21
ResultPPT
Transcript
Summary
Dec 20
ResultPPT
Transcript
Summary
Sep 20
ResultPPT
Transcript
Summary
Jun 20
ResultPPT
Transcript
Summary
Annual Reports
Quarterly Reports
Mar 26
ResultPPT
Transcript
Summary
Dec 25
ResultPPT
Transcript
Summary
Sep 25
ResultPPT
Transcript
Summary
Jun 25
ResultPPT
Transcript
Summary
Mar 25
ResultPPT
Transcript
Summary
Dec 24
ResultPPT
Transcript
Summary
Sep 24
ResultPPT
Transcript
Summary
Jun 24
ResultPPT
Transcript
Summary
Dec 23
ResultPPT
Transcript
Summary
Sep 23
ResultPPT
Transcript
Summary
Jun 23
ResultPPT
Transcript
Summary
Mar 23
ResultPPT
Transcript
Summary
Sep 22
ResultPPT
Transcript
Summary
Jun 22
ResultPPT
Transcript
Summary
Mar 22
ResultPPT
Transcript
Summary
Dec 21
ResultPPT
Transcript
Summary
Sep 21
ResultPPT
Transcript
Summary
Jun 21
Result
PPT
Transcript
Summary
Mar 21
ResultPPT
Transcript
Summary
Dec 20
ResultPPT
Transcript
Summary
Sep 20
ResultPPT
Transcript
Summary
Jun 20
ResultPPT
Transcript
Summary
Load More
Interviews